The Central Drugs Standard Control Organization is the Indian regulatory body for pharmaceuticals and medical devices, being the equivalent of the FDA in the US. The CDSCO is responsible for the regulating the manufacture, approval and sale of medical devices and drugs in India, for clinical trials as well as for providing expert advice on health issues and the enforcement of the Drugs and Cosmetics Act.
The department within the CDSCO responsible for regulating medical devices and drugs is known as the Drug Controller General of India (DCGI), in institution under the Indian Ministry of Health and Family Welfare. Inspections, audits, post-market surveillance and recalls are done through the department that is split into zonal offices.
Major Regulations
Some of the most important regulations for medical devices in India are:
A list of CDSCO regulations can be found here on our website.
Contact details:
Medical Device Associations in India:
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多自2022年5月26日始,欲在欧盟(EU)上市的新型体外诊断(IVD)医疗器械必须符合欧盟体外诊断医疗器械法规(2017/746 IVDR)。 同日起,带有有效CE标志的IVD可以继续按照指令98/79/EC(IVDD)进行销售,直至其许可证到期为止。 自2025年5月27日始,在欧盟销售的所
阅读更多